Complement-dependent proinflammatory properties of the Alzheimer's disease β-peptide

被引:224
作者
Bradt, BM
Kolb, WP
Cooper, NR
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] Adv Res Technol Inc, San Diego, CA 92121 USA
关键词
Alzheimer's disease; amyloid; C3; complement; inflammation;
D O I
10.1084/jem.188.3.431
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Large numbers of neuritic plaques (NP), largely composed of a fibrillar insoluble form of the beta-amyloid peptide (AP), are found in the hippocampus and neocortex of Alzheimer's disease (AD) patients in association with damaged neuronal processes, increased numbers of activated astrocytes and microglia, and several proteins including the components of the proinflammatory complement system. These studies address the hypothesis that the activated complement system mediates the cellular changes that surround fibrillar A beta deposits in NP. We report that A beta peptides directly and independently activate the alternative complement pathway as well as the classical complement pathway; trigger the formation of covalent, eater-linked complexes of A beta with activation products of the third complement component (C3); generate the cytokine-like C5a complement-activation fragment; and mediate formation of the proinflammatory C5b-9 membrane attack complex, in functionally active form able to insert into and permeabilize the membrane of neuronal precursor cells. These findings provide inflammation-based mechanisms to account for the presence of complement components in NP in association with damaged neurons and increased numbers of activated glial cells, and they have potential implications for the therapy of AD.
引用
收藏
页码:431 / 438
页数:8
相关论文
共 35 条
[11]   Reactive oxygen species as causal agents in the neurotoxicity of the Alzheimer's disease-associated amyloid beta peptide [J].
Hensley, K ;
Butterfield, DA ;
Hall, N ;
Cole, P ;
Subramaniam, R ;
Mark, R ;
Mattson, MP ;
Markesbery, WR ;
Harris, ME ;
Aksenov, M ;
Aksenova, M ;
Wu, JF ;
Carney, JM .
PHARMACOLOGICAL INTERVENTION IN AGING AND AGE-ASSOCIATED DISORDERS: PROCEEDINGS OF THE SIXTH CONGRESS OF THE INTERNATIONAL ASSOCIATION OF BIOMEDICAL GERONTOLOGY, 1996, 786 :120-134
[12]  
HUGLI TE, 1984, SPRINGER SEMIN IMMUN, V7, P193
[13]   Complement factor C5a and epidermal growth factor trigger the activation of outward potassium currents in cultured murine microglia [J].
Ilschner, S ;
Nolte, C ;
Kettenmann, H .
NEUROSCIENCE, 1996, 73 (04) :1109-1120
[14]  
JIANG HX, 1994, J IMMUNOL, V152, P5050
[15]   EXPRESSION OF THE RECEPTORS FOR THE C5A ANAPHYLATOXIN, INTERLEUKIN-8 AND FMLP BY HUMAN ASTROCYTES AND MICROGLIA [J].
LACY, M ;
JONES, J ;
WHITTEMORE, SR ;
HAVILAND, DL ;
WETSEL, RA ;
BARNUM, SR .
JOURNAL OF NEUROIMMUNOLOGY, 1995, 61 (01) :71-78
[16]  
LAW SK, 1979, J IMMUNOL, V123, P1388
[17]  
Mayer M.M., 1961, EXPT IMMUNOCHEMISTRY, P133
[18]   The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases [J].
McGeer, PL ;
McGeer, EG .
BRAIN RESEARCH REVIEWS, 1995, 21 (02) :195-218
[19]   IMMUNE-SYSTEM RESPONSE IN ALZHEIMERS-DISEASE [J].
MCGEER, PL ;
AKIYAMA, H ;
ITAGAKI, S ;
MCGEER, EG .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1989, 16 (04) :516-527
[20]   ACTIVATION OF THE CLASSICAL COMPLEMENT PATHWAY IN BRAIN-TISSUE OF ALZHEIMER PATIENTS [J].
MCGEER, PL ;
AKIYAMA, H ;
ITAGAKI, S ;
MCGEER, EG .
NEUROSCIENCE LETTERS, 1989, 107 (1-3) :341-346